Journal ArticleOPEN ACCESS

Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID-19 outbreak?

Clinical Case Reports (2021) 9(5)
DOI: 10.1002/ccr3.4249
4Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cyclosporine is an effective and safe immunosuppressant in the management of Toxic epidermal necrolysis (TEN) during COVID-19 outbreak for patients that intravenous immunoglobulin (IVIG) is contraindicated or is not affordable.

Author supplied keywords

Cite

CITATION STYLE

APA

Farajzadeh, S., & Ahramiyanpour, N. (2021). Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID-19 outbreak? Clinical Case Reports, 9(5). https://doi.org/10.1002/ccr3.4249

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free